DermTech (DMTKQ)
(Delayed Data from OTC)
$0.01 USD
+0.01 (104.29%)
Updated Aug 16, 2024 03:55 PM ET
3-Hold of 5 3
C Value C Growth A Momentum B VGM
DermTech, Inc. (DMTKQ) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$1.38 | $2.00 | $0.63 | N/A% |
Price Target
Based on short-term price targets offered by three analysts, the average price target for DermTech, Inc. comes to $1.38. The forecasts range from a low of $0.63 to a high of $2.00. The average price target represents no upside from the last closing price of $0.01.
Analyst Price Targets (3 )
Broker Rating
DermTech, Inc. currently has an average brokerage recommendation (ABR) of 3.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by three brokerage firms. The current ABR compares to an ABR of 3.00 a month ago based on three recommendations.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 1 | 1 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 3 | 3 | 3 | 3 | 3 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 3.00 | 3.00 | 3.00 | 2.50 | 2.50 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
4/19/2024 | BTIG | Mark Massaro | Strong Buy | Hold |
4/19/2024 | Lake Street Capital Markets | Thomas Flaten | Strong Buy | Hold |
3/5/2024 | Stephens | Mason Carrico | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 3.00 |
ABR (Last week) | 3.00 |
# of Recs in ABR | 3 |
Average Target Price | $1.38 |
LT Growth Rate | NA |
Industry | Medical Services |
Industry Rank by ABR | 165 of 253 |
Current Quarter EPS Est: | NA |